Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.

Saved in:

Bibliographic Details
Title:	Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.
Authors:	Khaemba C; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden.; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya., Barry A; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden., Omondi WP; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya., Bota K; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya., Matendechero S; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya., Wandera C; Ministry of Health -National Neglected Tropical Diseases Program, 30016-00100 Nairobi, Kenya., Siyoi F; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya., Kirui E; Ministry of Health -National Public Health Laboratory, Kenyatta National Hospital Grounds, 20750-00202 Nairobi, Kenya., Oluka M; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, 19676-00202 Nairobi, Kenya., Nambwa P; Pharmacy and Poisons Board, 27663-00506 Nairobi, Kenya., Gurumurthy P; Pharmacovigilance and Clinical Trials, Botswana Medicines Regulatory Authority, Gaborone 505155, Botswana., Njenga SM; Kenya Medical Research Institute (KEMRI), 54840-00200 Nairobi, Kenya., Guantai A; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, 19676-00202 Nairobi, Kenya., Aklillu E; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden.
Source:	Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Mar 15; Vol. 14 (3). Date of Electronic Publication: 2021 Mar 15.
Publication Type:	Journal Article
Journal Info:	Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1424-8247
DOI:	10.3390/ph14030264